Sesen Bio Inc reports results for the quarter ended in December - Earnings Summary

Carisma Therapeutics

28/02/2023 14:38

* Sesen Bio Inc  SESN.OQ  reported a quarterly adjusted loss
of 4
cents​​ per share for the quarter ended in December. The lone
analyst forecast for the quarter was for a loss of 11 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Sesen Bio Inc's reported EPS for the quarter was a loss
of 4
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Sesen Bio Inc shares had fallen by 4.3% this quarter.
    * The company reported a quarterly loss of $7.57 million.
    * Wall Street's median 12-month price target for Sesen Bio
Inc is
$0.60 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
28 at 02:38 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.11          -0.04          Beat
 Sep. 30 2022      -0.08          0.10           Beat
 Jun. 30 2022      -0.13          -0.16          Missed
 Mar. 31 2022      -0.10          0.00           Beat